GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Icon PLC (NAS:ICLR) » Definitions » Institutional Ownership

Icon (ICLR) Institutional Ownership : 74.89% (As of Apr. 26, 2024)


View and export this data going back to 1998. Start your Free Trial

What is Icon Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Icon's institutional ownership is 74.89%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Icon's Insider Ownership is 5.23%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Icon's Float Percentage Of Total Shares Outstanding is 99.06%.


Icon Institutional Ownership Historical Data

The historical data trend for Icon's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Icon Institutional Ownership Chart

Icon Historical Data

The historical data trend for Icon can be seen below:

2023-06-30 2023-07-31 2023-08-31 2023-09-30 2023-10-31 2023-11-30 2023-12-31 2024-01-31 2024-02-29 2024-03-31
Institutional Ownership 73.40 73.37 73.29 75.01 73.81 73.78 76.62 75.93 75.41 74.89

Icon Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Icon (ICLR) Business Description

Traded in Other Exchanges
Address
South County Business Park, Leopardstown, Dublin, IRL, D18 X5R3
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.